Skip to main content

Peer Review reports

From: Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial

Original Submission
22 Mar 2021 Submitted Original manuscript
18 Jun 2021 Reviewed Reviewer Report - Amanda Souza Silva-Sperb
17 Jul 2021 Reviewed Reviewer Report - Muslim Syed
22 Jul 2021 Reviewed Reviewer Report - Angela Bersch-Ferreira
9 Aug 2021 Reviewed Reviewer Report - Anamika Misra
11 Aug 2021 Author responded Author comments - Fatemeh Naeini
Resubmission - Version 2
11 Aug 2021 Submitted Manuscript version 2
13 Aug 2021 Reviewed Reviewer Report - Muslim Syed
23 Aug 2021 Reviewed Reviewer Report - Angela Bersch-Ferreira
30 Aug 2021 Reviewed Reviewer Report - Amanda Souza Silva-Sperb
1 Sep 2021 Author responded Author comments - Fatemeh Naeini
Resubmission - Version 3
1 Sep 2021 Submitted Manuscript version 3
28 Sep 2021 Reviewed Reviewer Report - Muslim Syed
3 Oct 2021 Reviewed Reviewer Report - Amanda Souza Silva-Sperb
12 Oct 2021 Author responded Author comments - Fatemeh Naeini
Resubmission - Version 4
12 Oct 2021 Submitted Manuscript version 4
21 Oct 2021 Reviewed Reviewer Report - Muslim Syed
27 Oct 2021 Reviewed Reviewer Report - Amanda Souza Silva-Sperb
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
2 Nov 2021 Editorially accepted
13 Nov 2021 Article published 10.1186/s13063-021-05784-7

You can find further information about peer review here.

Back to article page